Abstract:Background and Aims: To explore and evaluate the clinical therapeutic effect of interventional occlusion in the treatment of patent foramen ovale (PFO) with positive foaming test in the prevention and treatment of cryptogenic stroke (CS) and to provide clinical basis for individualized treatment of CS patients with PFO. Methods: A total of 151 patients who was admitted to Beijing Anzhen Nanchong Hospital Hospital from January 2019 to June 2021 were divided into two groups: drug therapy group (n = 63) and interventional occlusion + drug therapy group (n = 88). The general clinical data of the patients were collected by retrospective study, including sex, age, body weight, right to left shunt (RLS) magnitude, the degree of migraine before treatment, and telephone follow-up of all patients after treatment. Results: There was no significant difference in general clinical data (p > 0.05). In the interventional occlusion + drug therapy group, the stroke recurrence rate within 6th month after operation was significantly lower than that in the drug therapy group, and the difference was statistically significant (p < 0.05); The degree of migraine was lower than that in the drugs treatment group at the 3rd month after operation and the difference was statistically significant (p 0.05). The results of comprehensive generalized analysis showed that the risk of moderate or severe headache in the interventional occlusion + drug therapy group decreased by 40% (odds ratio [OR] = 0.60, p < 0.05). The degree of migraine in female patients was statistically lower after three and six months postoperatively (p < 0.05 and p = 0.01, respectively). Combined with generalized analysis, the risk of moderate or severe migraine in female patients was reduced by 55%. There were significant differences in the migraine before operation, migraine at the 3rd month and migraine at the 6th month in patients with three different kinds RLS grades (p < 0.01, p < 0.01, p < 0.05). Compared with the preoperative migraine and the migraine at the 3rd month, patients with RLS grade 3 had the most obvious migraine relief at the 6th month after operation than those with RLS grade 2. Conclusion: Compared with the drug therapy, interventional occlusion + drug therapy can reduce the risk of CS recurrence, improve the prognosis and significantly reduce the degree of migraine. Patients of different genders had different degrees of migraine, women had a lighter degree of migraine and a reduced risk of moderate or severe migraine, women benefited more after treatment. Patients with different RLS grades have different postoperative migraine relief. Patients with preoperative RLS grade 3 have the most obvious postoperative migraine relief and patients with preoperative RLS grade 3 benefit more after treatment.

Research progress in Patent foramen ovale and cryptogenic stroke

Comparison of Stroke Recurrence Between Antiplatelet and Closure Therapy in Cryptogenic Stroke Patients with Patent Foramen Ovale and Its Influencing Factors

Drug therapy of patent foramen ovale with cryptogenic stroke

Patent Foramen Ovale Closure for Patients with Cryptogenic Stroke: A Systematic Review and Comprehensive Meta‐analysis of 5 Randomized Controlled Trials and 14 Observational Studies

Patent Foramen Ovale and Stroke–Current Status

Diagnosis and treatment progresses of patent foramen ovale complicated with ischemic stroke

Clinical study of transcatheter closure of patent foramen ovale with cryptogenic stroke

Percutaneous Patent Foramen Ovale Closure in Patients with Cryptogenic Stroke or Transient Ischemic Attack: A Retrospective Study.

Assessment of the Characteristics of Patent Foramen Ovale Associated with Cryptogenic Stroke

Recent Progress in Patent Foramen Ovale and Related Neurological Diseases: A Narrative Review.

Patent Foramen Ovale Closure Vs. Medical Therapy Alone after Cryptogenic Stroke in China: A Cost-Effectiveness Analysis

Research status of the radiographic features of patients with cryptogenic cerebral infarction related to patent foramen ovale

Patent Foramen Ovale: a Comprehensive Review for Pulmonologists

Clinical and Infarction Patterns of PFO‐related Cryptogenic Strokes and a Prediction Model

Closing Patent Foramen Ovale in Cryptogenic Stroke: the Underscored Importance of Other Interatrial Shunt Variants

Clinical Efficacy of Transcatheter Closure of Patent Foramen Ovale with Positive Foaming Test

Evidence of Percutaneous Patent Foramen Ovale Closure for Cryptogenic Stroke

Research Progress of Paroxysmal Atrial Fibrillation and Cryptogenic Stroke

Treatment Strategies for Cryptogenic Stroke Patients with Patent Foramen Ovale: What Do We Choose?

Echocardiography in diagnosis of patent foramen ovale

Management of Patients with Patent Foramen Ovale and Cryptogenic Stroke: a Collaborative, Multidisciplinary, Position Paper.